Subcutaneous injection of Vedolizumab an efficient treatment for Crohn's disease

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2021-11-17 03:30 GMT | Update On 2021-11-23 10:46 GMT

The content on this page is available only on Mobile App. Please download the Mobile app to read this content

Download the Medical Dialogue App Now

Article Source : Journal of Crohn’s and Colitis

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

MD Editorial Team

Medical Dialogues consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Subcutaneous injection of Vedolizumab an efficient treatment for Crohn's disease

Similar News